↓ Skip to main content

Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: I. Effects on lung remodeling and pathology

Overview of attention for article published in Respiratory Research, October 2013
Altmetric Badge

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
21 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: I. Effects on lung remodeling and pathology
Published in
Respiratory Research, October 2013
DOI 10.1186/1465-9921-14-113
Pubmed ID
Authors

Hoeke A Baarsma, Sophie Bos, Herman Meurs, Kim H Visser, Marieke Smit, Annemie MWJ Schols, Ramon C Langen, Huib AM Kerstjens, Reinoud Gosens

Abstract

Glycogen synthase kinase-3 (GSK-3) is a constitutively active kinase that regulates multiple signalling proteins and transcription factors involved in a myriad of cellular processes. The kinase acts as a negative regulator in β-catenin signalling and is critically involved in the smad pathway. Activation of both pathways may contribute to pulmonary features of chronic obstructive pulmonary disease (COPD).

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 19%
Student > Ph. D. Student 3 14%
Student > Bachelor 3 14%
Student > Master 3 14%
Student > Doctoral Student 1 5%
Other 5 24%
Unknown 2 10%
Readers by discipline Count As %
Medicine and Dentistry 7 33%
Agricultural and Biological Sciences 5 24%
Pharmacology, Toxicology and Pharmaceutical Science 4 19%
Biochemistry, Genetics and Molecular Biology 2 10%
Unknown 3 14%